Imidazopyridine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancer

Also, the novel imidazopyridine derivative according to the present invention, the stereoisomer thereof, and the pharmaceutically acceptable salt thereof can effectively inhibit Src and Fyn, thereby being useful as a pharmaceutical composition for preventing or treating the Src and Fyn related disea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Choi, Dong Kyu, Ryu, Hee Yoon, Kim, Sangbum, Park, Jin-Hee, Kim, Nam Doo, Bae, Jae Hyun, Kim, Dayea, Kim, So Young, Kim, Hyunkyoung, Kang, Seock Yong, Son, Jung Beom, Yoon, Suk Kyoon, Lee, Seungyeon, Cho, Joongheui, Lee, Sun Joo, Ko, Eunhwa, Kim, Shinae, Min, Sang Hyun, Hong, Seongho, Song, Jaeyoung, Ko, Yi Kyung, Lee, Younho, Jang, Tae-Ho, Lee, Sun-Hwa, Choi, Hwan Geun, Hong, Eunmi, Lee, Sungwoo
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Also, the novel imidazopyridine derivative according to the present invention, the stereoisomer thereof, and the pharmaceutically acceptable salt thereof can effectively inhibit Src and Fyn, thereby being useful as a pharmaceutical composition for preventing or treating the Src and Fyn related diseases, and in particular, have been confirmed to be useful in diabetic nephropathy in animal model experiments. Therefore, the compound of the present invention can be effective as a pharmaceutical composition containing the same as an active ingredient for preventing or treating diabetic nephropathy.